TheraVet: Significant Sales Progression for BIOCERA-VET® in Q3 2023
GOSSELIES, Belgium, November 08, 2023--Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces significant progression for BIOCERA-VET® line in the third quarter of 2023.